Treatment of chronic myeloid leukemia with imatinib: IRIS study

被引:0
|
作者
Saußele S. [1 ]
Nitschmann S. [2 ]
机构
[1] III. Medizinische Klinik, Universitätsmedizin Mannheim, Theodor-Kutzer-Ufer 1–3, Mannheim
来源
Der Internist | 2017年 / 58卷 / 11期
关键词
D O I
10.1007/s00108-017-0322-0
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:1220 / 1221
页数:1
相关论文
共 50 条
  • [21] Treatment selection after imatinib resistance in chronic myeloid leukemia
    Elias Jabbour
    Jorge Cortes
    Hagop Kantarjian
    Targeted Oncology, 2009, 4 : 3 - 10
  • [22] Comparison of the Efficacy of Nilotinib and Imatinib in the Treatment of Chronic Myeloid Leukemia
    Zhang, Bang-Shuo
    Chen, Yong-Ping
    Lv, Jing-Long
    Yang, Yi
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2019, 29 (07): : 631 - 634
  • [23] Generic imatinib in the treatment of chronic myeloid leukemia: Cerrahpasa experience
    Eskazan, Ahmet Emre
    Soysal, Teoman
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2016, 22 (02) : 382 - 384
  • [24] Criteria and treatment of insufficient responses to imatinib in chronic myeloid leukemia
    Rousselot, Philippe
    HEMATOLOGIE, 2006, 12 : 19 - 25
  • [25] Treatment selection after imatinib resistance in chronic myeloid leukemia
    Jabbour, Elias
    Cortes, Jorge
    Kantarjian, Hagop
    TARGETED ONCOLOGY, 2009, 4 (01) : 3 - 10
  • [26] Chronic myeloid leukemia in the imatinib era
    Druker, BJ
    SEMINARS IN HEMATOLOGY, 2003, 40 (02) : 1 - 3
  • [27] Imatinib in Chronic Myeloid Leukemia: an Overview
    Sacha, Tomasz
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2014, 6 (01)
  • [28] Imatinib in chronic myeloid leukemia - Reply
    Druker, Brian
    Gathmann, Insa
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (17): : 1780 - 1780
  • [29] Imatinib Mesylate in Chronic Myeloid Leukemia
    Mishra, Pravas
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (01) : 5 - 6
  • [30] Imatinib therapy in chronic myeloid leukemia
    Crossman, LC
    O'Brien, SG
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (03) : 605 - +